Diabetic Retinopathy Prevalence And Risk Factors
DR-CENTRAL
1 other identifier
observational
300
1 country
1
Brief Summary
The goal of this retrospective observational study is to evaluate the prevalence and severity of diabetic retinopathy (DR) and to identify associated risk factors among patients with diabetes mellitus at Gia Dinh Family Hospital in Da Nang, Vietnam. The main questions it aims to answer are:
- 1.What is the prevalence and distribution of different stages of diabetic retinopathy among diabetic patients at this hospital?
- 2.Which clinical and laboratory factors are associated with the presence of diabetic retinopathy?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 25, 2025
CompletedFirst Submitted
Initial submission to the registry
February 25, 2026
CompletedFirst Posted
Study publicly available on registry
March 12, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2026
CompletedMarch 12, 2026
November 1, 2025
4 months
February 25, 2026
March 10, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Prevalence of diabetic retinopathy (any stage)
To determine the prevalence of diabetic retinopathy among patients with diabetes mellitus.
At baseline (data collected at the time of retinal examination during the study period, January-September 2025)
Interventions
Patients will be identified through the Ehealth program at the Family Hospital, Da Nang. All diabetic patients who visited the Center of Endocrinology and Diabetes and had ophthalmologic examination, including fundus examination and optical coherence tomography (OCT), during the study period will be screened for eligibility
Eligibility Criteria
This hospital-based retrospective cohort study included adult patients with diabetes mellitus who attended the Endocrinology-Diabetes Center and underwent ophthalmologic evaluation at the Eye Clinic of Family General Hospital, Da Nang, Vietnam, between January 2025 and September 2025.
You may qualify if:
- Diagnosed diabetes mellitus (type 1 or type 2) according to ADA criteria
- Underwent ophthalmic examination including dilated fundus examination and OCT
- Available electronic medical records with key clinical and laboratory data
You may not qualify if:
- Gestational diabetes mellitus
- Media opacity precluding fundus examination (advanced cataract, corneal opacity, dense vitreous hemorrhage)
- Other retinal diseases (e.g., hypertensive retinopathy, retinal vein occlusion)
- History of ocular trauma or intraocular surgery within 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Endocrinology and Diabetes
Da Nang, 50000, Vietnam
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thao Nguyen Ngoc, Doctor of Medicine
Family Hospital, Da Nang, Vietnam
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 25, 2026
First Posted
March 12, 2026
Study Start
November 25, 2025
Primary Completion
March 15, 2026
Study Completion
March 30, 2026
Last Updated
March 12, 2026
Record last verified: 2025-11